How the drug allergy risk in the intensive care software is considered? About a comparative study

The aim of this study was to evaluate the way the drug allergy risk was considered in five intensive care software available for the French market. It is an observational study conducted by a survey with the five firms asked during the 26th International Symposium on Intensive Care and Emergency Med...

Full description

Saved in:
Bibliographic Details
Published inAnnales françaises d'anesthésie et de réanimation Vol. 27; no. 3; pp. 230 - 233
Main Authors Pasquier, P, Perez, J-P, Clapson, P, Debien, B, Vichard, A, Lenoir, B
Format Journal Article
LanguageFrench
Published France 01.03.2008
Subjects
Belgium
Congresses as Topic
Critical Care - standards
Drug Hypersensitivity - diagnosis
Drug Hypersensitivity - prevention & control
Emergency Medicine - standards
France
Health Surveys
Humans
Intensive Care Units - standards
Software
Belgium
France
Online AccessGet full text

Cover

More Information
Summary:The aim of this study was to evaluate the way the drug allergy risk was considered in five intensive care software available for the French market. It is an observational study conducted by a survey with the five firms asked during the 26th International Symposium on Intensive Care and Emergency Medicine in Brussels (March 2006). The drug allergic risk is documented to various degrees among the software selections. However, no software proposes an alternative or blocking of the prescription in case of allergy to a drug.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1769-6623
DOI:10.1016/j.annfar.2007.12.009